Striepen B, Zinecker C F, Damm J B, Melgers P A, Gerwig G J, Koolen M, Vliegenthart J F, Dubremetz J F, Schwarz R T
Zentrum für Hygiene und Medizinische Mikrobiologie Philipps-Universität Marburg, Germany.
J Mol Biol. 1997 Mar 7;266(4):797-813. doi: 10.1006/jmbi.1996.0806.
Toxoplasma gondii is a ubiquitous parasitic protozoan causing congenital infection and severe encephalitis in the course of the acquired immunodeficiency syndrome. Glycosyl-phosphatidylinositols of T. gondii have been shown to be identical with the low molecular weight antigen which elicits an early immunoglobulin M immune response in humans. A detailed study of the structures of these glycolipid antigens was performed. Radiolabelled glycolipids were extensively analysed by chemical and exoglycosidase treatments in combination with high pH anion-exchange chromatography, gel-filtration and lectin affinity chromatography. In addition, carbohydrate fragments prepared and purified from bulk preparations of unlabelled glycolipids by high performance liquid chromatography were subjected to two-dimensional 1H nuclear magnetic resonance spectroscopy, fast-atom bombardment-mass spectrometry, and methylation linkage analysis in order to elucidate the structure of T. gondii GPIs. The following structures were identified: (ethanolamine-PO4)-Man alpha 1-2Man alpha 1-6(GalNAc beta 1-4)Man alpha 1-4GlcN alpha-inositol-PO4-lipid and the novel structure (ethanolamine-PO4)-Man alpha 1-2Man alpha 1-6(Glc alpha 1-4GalNAc beta 1-4)Man alpha 1-4 GlcN alpha-inositol-PO4-lipid both with and without terminal ethanolamine phosphate. Evidence is provided, that only T. gondii GPIs bearing the unique glucose-N-acetylgalactosamine side branch are immunogenic in humans and that this structure is widely distributed among T. gondii isolates. Monoclonal antibodies have been characterized to recognize structures with different degrees of side-chain modification. We suggest that these reagents in combination with recently devised techniques for insertional mutagenesis in T. gondii should greatly facilitate the cloning of genes essential for GPI side-chain modification.
刚地弓形虫是一种普遍存在的寄生原生动物,可导致先天性感染以及在获得性免疫缺陷综合征病程中引发严重脑炎。已证明刚地弓形虫的糖基磷脂酰肌醇与低分子量抗原相同,该抗原可在人类中引发早期免疫球蛋白M免疫反应。对这些糖脂抗原的结构进行了详细研究。通过化学和外切糖苷酶处理,并结合高pH值阴离子交换色谱法、凝胶过滤和凝集素亲和色谱法,对放射性标记的糖脂进行了广泛分析。此外,通过高效液相色谱法从未标记糖脂的大量制剂中制备和纯化的碳水化合物片段,进行了二维1H核磁共振光谱、快原子轰击质谱和甲基化连接分析,以阐明刚地弓形虫糖基磷脂酰肌醇(GPI)的结构。鉴定出以下结构:(乙醇胺 - 磷酸)-甘露糖α1-2-甘露糖α1-6(N-乙酰半乳糖胺β1-4)-甘露糖α1-4-葡糖胺α-肌醇-磷酸-脂质,以及新结构(乙醇胺 - 磷酸)-甘露糖α1-2-甘露糖α1-6(葡萄糖α1-4-N-乙酰半乳糖胺β1-4)-甘露糖α1-4-葡糖胺α-肌醇-磷酸-脂质,两者均有或没有末端乙醇胺磷酸。有证据表明,只有带有独特葡萄糖-N-乙酰半乳糖胺侧链的刚地弓形虫GPI在人类中具有免疫原性,并且该结构在刚地弓形虫分离株中广泛分布。已对单克隆抗体进行了表征,以识别具有不同程度侧链修饰的结构。我们认为,这些试剂与最近设计的用于刚地弓形虫插入诱变的技术相结合,应极大地促进GPI侧链修饰所必需基因的克隆。